Loading...
Real-world outcomes with ranibizumab in branch retinal vein occlusion: The prospective, global, LUMINOUS study
OBJECTIVE: To evaluate the effectiveness, safety, and treatment patterns of ranibizumab 0.5 mg in treatment-naïve patients with branch retinal vein occlusion (BRVO) enrolled in the LUMINOUS(™) study. STUDY DESIGN: A 5-year, global, prospective, multicenter, observational, open-label study conducted...
Na minha lista:
| Udgivet i: | PLoS One |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Public Library of Science
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7302470/ https://ncbi.nlm.nih.gov/pubmed/32555630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0234739 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|